Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Elution from Bone Cement in TKA
NCT05429671Phase 3Completed
- Sponsor
- Rothman Orthopaedics
- Start
- Jun 2022
- Primary completion
- Nov 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of tobramycin, gentamicin in periprosthetic joint infection (PJI), sponsored by Rothman Orthopaedics. Started Jun 2022; status: completed.
02
Drugs
tobramycingentamicin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT05429671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429671.